{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:32:44Z","timestamp":1790652764199,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Androl"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/1008-682x.125912","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T07:05:27Z","timestamp":1400051127000},"page":"740","source":"Crossref","is-referenced-by-count":4,"title":["A population study of fasting time and serum prostate-specific antigen (PSA) level"],"prefix":"10.4103","volume":"16","author":[{"given":"ChristopherT","family":"Naugler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CherylK","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JeannineA","family":"Viczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1008-682X.125912-1","unstructured":"Prostate Cancer. Available from: http:\/\/www.phac-aspc.gc.ca\/cd-mc\/cancer\/prostate_cancer-cancer_prostate-eng [Last accessed on 2013 Aug 22]."},{"key":"key-10.4103\/1008-682X.125912-2","unstructured":"Canadian Cancer Statistics 2013. Available from: http:\/\/www.cancer.ca\/en\/cancer-information\/cancer-101\/canadian-cancer-statistics-publication\/?region=ab [Last accessed on 2013 Aug 22]."},{"key":"key-10.4103\/1008-682X.125912-3","first-page":"337","volume-title":"Prostate-specific antigen and detection of prostate cancer: what have we learned and what should we recommend for screening?","author":"Amling","year":"2006","journal-title":"Curr Treat Options Oncol"},{"key":"key-10.4103\/1008-682X.125912-4","first-page":"2252","volume-title":"Biomarkers for prostate cancer detection","author":"Parekh","year":"2007","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.125912-5","first-page":"1853","volume-title":"Prostate-specific antigen in the early detection of prostate cancer","author":"Thompson","year":"2007","journal-title":"CMAJ"},{"key":"key-10.4103\/1008-682X.125912-6","first-page":"914","volume-title":"Prostate cancer screening: what we know and what we need to know","author":"Kramer","year":"1993","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1008-682X.125912-7","first-page":"70","volume-title":"Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer","author":"Bunting","year":"1999","journal-title":"CMAJ"},{"key":"key-10.4103\/1008-682X.125912-8","first-page":"S2","volume-title":"Trends in incidence and mortality of prostate cancer in Canada","author":"Levy","year":"1995","journal-title":"Chronic Dis Can"},{"key":"key-10.4103\/1008-682X.125912-9","first-page":"111","volume-title":"Prevalence of PSA testing and effect of clinical indications on patterns of PSA testing in a population-based sample of Alberta men","author":"McGregor","year":"2002","journal-title":"Chronic Dis Can"},{"key":"key-10.4103\/1008-682X.125912-10","first-page":"CD004720","volume-title":"Screening for prostate cancer","author":"Ilic","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/1008-682X.125912-11","unstructured":"Screening and Early Diagnosis of Prostate Cancer. Available from: http:\/\/www.topalbertadoctors.org\/cpgs\/?sid=2&cpg_cats=26 [Last accessed on 2013 Aug 22]."},{"key":"key-10.4103\/1008-682X.125912-12","first-page":"197","volume-title":"Recommendations by Canadian urologists and radiation oncologists for the treatment of clinically localized prostate cancer","author":"Pearce","year":"2008","journal-title":"Can Urol Assoc J"},{"key":"key-10.4103\/1008-682X.125912-13","first-page":"235","volume-title":"Prostate cancer screening: Canadian guidelines 2011","author":"Izawa","year":"2011","journal-title":"Can Urol Assoc J"},{"key":"key-10.4103\/1008-682X.125912-14","first-page":"251","volume-title":"The effect of cystoscopy on PSA levels in patients with urologic diseases","author":"Bastani","year":"2010","journal-title":"Int J Nephrol Urol"},{"key":"key-10.4103\/1008-682X.125912-15","first-page":"511","volume-title":"Ejaculation increases the serum prostate-specific antigen concentration","author":"Tchetgen","year":"1996","journal-title":"Urology"},{"key":"key-10.4103\/1008-682X.125912-16","first-page":"94","volume-title":"Influence of a light meal on routine haematological tests","author":"Lippi","year":"2010","journal-title":"Blood Transfus"},{"key":"key-10.4103\/1008-682X.125912-17","first-page":"1707","volume-title":"Fasting time and lipid levels in a community-based population: a cross-sectional study","author":"Sidhu","year":"2012","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/1008-682X.125912-18","first-page":"105","volume-title":"Is serum prostate-specific antigen level affected by fasting and nonfasting?","author":"Tuncel","year":"2005","journal-title":"Urology"},{"key":"key-10.4103\/1008-682X.125912-19","first-page":"2047","volume-title":"Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction","author":"Langsted","year":"2008","journal-title":"Circulation"},{"key":"key-10.4103\/1008-682X.125912-20","first-page":"250","volume-title":"Influence of a regular, standardized meal on clinical chemistry analytes","author":"Lima-Oliveira","year":"2012","journal-title":"Ann Lab Med"},{"key":"key-10.4103\/1008-682X.125912-21","first-page":"1601","volume-title":"European guidelines on cardiovascular disease prevention in clinical practice.Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice","author":"De","year":"2003","journal-title":"Eur Heart J"},{"key":"key-10.4103\/1008-682X.125912-22","first-page":"3143","volume-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","author":"National","year":"2002","journal-title":"Circulation"},{"key":"key-10.4103\/1008-682X.125912-23","first-page":"1032","volume-title":"Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice","author":"Csapo","year":"1988","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.125912-24","first-page":"987","volume-title":"The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia","author":"Weber","year":"1989","journal-title":"J Urol"},{"key":"key-10.4103\/1008-682X.125912-25","first-page":"63","volume-title":"Temporal variations of testosterone levels in the peripheral blood plasma of men","author":"Rowe","year":"1974","journal-title":"J Endocrinol"},{"key":"key-10.4103\/1008-682X.125912-26","first-page":"337","volume-title":"Relationship between diurnal rhythm of serum testosterone and two prostatic markers (PSA and PAP) in untreated prostate cancer","author":"Akimoto","year":"1994","journal-title":"Urology"},{"key":"key-10.4103\/1008-682X.125912-27","first-page":"288","volume-title":"Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation","author":"Dejter","year":"1988","journal-title":"Urology"},{"key":"key-10.4103\/1008-682X.125912-28","first-page":"88","volume-title":"Serum prostate-specific antigen: hourly change\/24 hours compared with prostatic acid phosphatase","author":"el-Shirbiny","year":"1990","journal-title":"Urology"},{"key":"key-10.4103\/1008-682X.125912-29","first-page":"9","volume-title":"Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer","author":"Mannini","year":"1988","journal-title":"Urol Res"},{"key":"key-10.4103\/1008-682X.125912-30","first-page":"641","volume-title":"Daily variability of serum prostate-specific antigen in men over 50 years of age","author":"Tekin","year":"2001","journal-title":"Int Urol Nephrol"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:26:33Z","timestamp":1786649193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1008-682X.125912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"alternative-id":["125912"],"URL":"https:\/\/doi.org\/10.4103\/1008-682x.125912","relation":{},"ISSN":["1008-682X"],"issn-type":[{"value":"1008-682X","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}